Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study.
Ali Reza SobhaniHossein FarshidiFariba AzarkishMahdiya EslamiEbrahim EftekharMansoor KeshavarzNepton SoltaniPublished in: Clinical pharmacology : advances and applications (2020)
The results of this study showed that despite the slight change in serum magnesium level, oral administration of MgSO4for six months could slightly reduce the serum levels of some inflammatory and vascular factors in moderate coronary artery disease patients.
Keyphrases
- end stage renal disease
- clinical trial
- coronary artery disease
- coronary artery
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cardiovascular disease
- prognostic factors
- oxidative stress
- randomized controlled trial
- high intensity
- acute coronary syndrome
- pulmonary artery
- study protocol
- atrial fibrillation
- left ventricular
- pulmonary arterial hypertension
- phase ii